2018, Number 3
<< Back Next >>
Cir Cir 2018; 86 (3)
Identification of drugs as regulators on the activity of Egr-1 promoter in human fibroblasts transduced with Ad Δegr-1-Luc7
Martínez-Flores F, Sandoval H, Arce VE, García-Cavazos RJ, Jiménez-Orozco FA, Valdes-Flores M, Madinaveitia-Villanueva JA
Language: Spanish
References: 23
Page: 237-243
PDF size: 527.24 Kb.
ABSTRACT
Introduction: The early growth response protein (EGR-1) is a transcription factor involved in cell differentiation and proliferation,
whose expression is regulated by its promoter in response to various physical, chemical and drug factors. Hereby, we
describe some of the main effects of steroid drugs and EGF-1 on promoter activity, through a reporter system transduced by
Ad
Δegr-1-Luc7 in human primary fibroblasts (HPF).
Methods: Human primary fibroblasts transduced with Ad
Δegr-1-Luc7 were
exposed to betamethasone, hydrocortisone, dexamethasone, testosterone, beta-estradiol, and EGF-1 during 1, 3 and 6 h.
Reporter assay was quantified by luminometry.
Results: The activity of the promoter in presence of betamethasone, hydrocortisone,
dexamethasone, testosterone and beta-estradiol were similar to the basal activity of the promoter at 1, 3 and 6 h.
The positive control showed an activity 17.8 folds higher (p ≤ 0.05) at 6 h. EGF-1 showed activity of 22.07 folds greater than cells without drug.
Conclusion: The activity of the EGR-1 promoter in human fibroblasts is negatively regulated by steroid
drugs and positively by the EGF-1.
REFERENCES
Sukhatme VP. Early transcriptional events in cell growth: the Egr family. J Am Soc Nephrol. 1990;1:859-66.
Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, Lauriola M, et al. Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Mol Cell. 2011;42:524-35.
Sakamoto KM, Fraser JK, Lee HJ, Lehman E, Gasson JC. Granulocyte macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter. Mol Cell Biol. 1994;14 5975-85.
Sakamoto KM, Bardeleben C, Yates KE, Raines MA, Golde DW, Gasson JC. 5’ upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene. 1991;6:867-71.
Aicher WK, Sakamoto KM, Hack A, Eibel H. Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol Int. 1999;18:207-14.
Schwachtgen JL, Campbell CJ, Braddock M. Full promoter sequence of human early growth response factor-1 (Egr-1): demonstration of a fifth functional serum response element. DNA Seq. 2000;10:429-32.
Rolli M, Kotlyarov A, Sakamoto KM, Gaestel M, Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. J Biol Chem. 1999;274: 19559-64.
Mora-Garcia P, Sakamoto KM. Granulocyte colony-stimulating factor induces Egr-1 up-regulation through interaction of serum response element- binding proteins. J Biol Chem. 2000;275:22418-26.
Huang RP, Fan Y, Boynton AL. UV irradiation upregulates Egr-1 expression at transcription level. J Cell Biochem. 1999;73:227-36.
Martínez-Flores F, Machuca-Rodríguez C, Sandoval-Zamora H, Aguirre-Cruz L, Valdez-Flores M, Villegas-Castrejón H. Steroid drugs and GM-CSF modulates activity of EGR-1 in glioma cells. Cir Cir. 2013;81: 3-13.
Pritchard MT, Malinak RN, Nagy LE. Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1124-31.
He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998;95:2509-14.
Martínez-Flores F, Jiménez-Orozco FA, Villegas-Castrejón H. Molecular biology of adenoviral vectors. Cir Cir. 2006;74:483-93.
Hsu H, Rainov NG, Quinones A, Eling DJ, Sakamoto KM, Spear MA. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Res. 2003;23:2723-8.
Ernst A, Aigner M, Nakata S, Engel F, Schlotter M, Kloor M, et al. A gene signature distinguishing CD133hi from CD133-colorectal cancer cells: essential role for EGR1 and downstream factors. Pathology. 2011;43: 220-7.
Neuhaus T, Stier S, Totzke G, Gruenewald E, Fronhoffs S, Sachinidis A, et al. Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif. 2003;36:75-86.
Perogamvros I, Ray DW, Trainer PJ. Regulation of cortisol bioavailability effects on hormone measurement and action. Nat Rev Endocrinol 2012;8:717-27.
Stahn C, Löwenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 2007;275:71-8.
Pezzoli D, Chiesa R, De Nardo L, Candiani G. We still have a long way to go to effectively deliver genes! J Appl Biomater Function Mater. 2012;27;10 e82-91.
Runge-Morris M, Rose K, Kokarec TA. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones. Drug Metab Dispos. 1996;24:1095-101.
Shin SY, Kim JH, Baker A, Lim Y, Lee YH. Transcription factor Egr-1 is essential for maximal matrix metalloproteinase-9 transcription by tumor necrosis factor alpha. Mol Cancer Res. 2010;8 507-19.
Tiganescu A, Tahrani AA, Morgan SA, Otranto M, Desmoulière A, Abrahams L, et al. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects. J Clin Invest. 2013;123:3051-3060.
Werth BB, Bashir M, Chang L, Werth VP. Ultraviolet irradiation induces the accumulation of chondroitin sulfate, but not other glycosaminoglycans, in human skin. PLoS One. 2011;6:e14830.